Gina Mauro

Vice President, Content

New Jersey

Driven and passionate journalist and videographer who creates captivating stories across multiple platforms, while building a company rapport with audience through social media. Award-winning editor and reporter seeking a challenging environment that promotes career development.

Gina Mauro

Vice President, Content

New Jersey

OncLive News Network On Location: In Chicago Friday, June 1
The combination of ibrutinib and rituximab showed superior efficacy when compared with rituximab plus placebo in patients with Waldenstrom’s macroglobulienma, according to phase III data presented at the meeting. At a median follow-up of 26.5 months, the doublet therapy prolonged progression-free survival versus rituximab and placebo in all patients regardless of prognostic or genetic factors.
OncLive
Oncology
N.J. schools ask students to bring their own tech
There was a time in the not-too-distant past when bringing a cellphone or other hand-held digital device to school could earn a kid detention or a visit to the principal's office. Today, however, many schools aren't just allowing kids to tote their tablets, smartphones and laptops to class — they're asking students to bring in their tech.
USA Today
Education
ASCO 2018: Top Oncologists Select Key, Practice-Changing Abstracts
The oncology community will soon be seeing the much-anticipated data being presented at the 2018 ASCO Annual Meeting. More than 5000 submitted abstracts will showcase findings across tumor types, which include practice-changing research in screening, immunotherapy, targeted agents, chimeric antigen receptor (CAR) T-cell therapy, and more.
OncLive
Oncology
Some parents don't know how to handle kids' deceit
Though children may not think they're doing anything wrong, more than one-third of 3-year-olds lie. And by the time they are 4 to 7, half of the tykes tell 'non-truths.'
USA Today
OncLive News Network On Location: In San Diego Monday, December 3
We are on site at the San Diego Convention Center in California at the 2018 ASH Annual Meeting! We have recapped the top news each day during the meeting—and soon we’ll speak with Dr Owen O’Connor on some encouraging lymphoma abstracts, Dr William Wierda on exciting chronic lymphocytic leukemia studies, and Dr Brad Kahl on the latest in non-Hodgkin lymphoma.
OncLive
Oncology Education
N.J. 6-year-old shooting victim mourned at funeral
As they gathered outside St. Joseph's Church on Saturday with tears in their eyes, family, friends and neighbors remembered Brandon Holt as a little boy who was full of life.
USA Today
News
FDA Approves Tagraxofusp for Rare Hematologic Cancer
The FDA has approved tagraxofusp-erzs (SL-401; Elzonris) infusion for the treatment of adult and pediatric patients, aged ≥2 years, with blastic plasmacytoid dendritic cell neoplasm (BPDCN).1. The approval is based on data from 2 cohorts of a multicenter, open-label, nonrandomized single-arm trial.
OncLive
Oncology
Love of Jersey landmarks unites fans on Facebook
Since July 25, there have been more than 30,000 posts from people sharing and reliving their Jersey Shore memories.
USA Today
Features
Same-sex couples mark forever with elegance
Aaron Coleman said his wedding day to husband Tony Austin was one of the most beautiful experiences of his life.
Asbury Park Press
Indulge
'Walk with me through Long Beach Island'
It's a blazin' summer day driving over the Dorland J. Henderson Memorial Bridge. Traffic is beginning to brew. The Barnegat Bay and Little Egg Harbor Bay are all glistening as sun rays beat down on them.
Asbury Park Press
Features Get Out
Viking Yachts take luxury to new heights
Right off Exit 52 on the Garden State Parkway, mobile treasures are being built inside the 810,000-square-foot facility of Viking Yachts. And while strolling through this property — on the Bass River in New Gretna — one cannot help but be fascinated at the glorious ships awaiting their first cruise.
Asbury Park Press
Features Luxury Living
Meet the hottest soap stars this weekend in Jersey
The straightforward, no-nonsense attitude of the people. A home away from home. The culture. And who can forget the huge fan base? They're all parts of New Jersey that keep soap opera stars coming back for more. "I feel such a connection with East Coast people, especially people from Jersey and areas like that, because I just feel they're so much more 'what you see is what you get,' " says Vanessa Marcil, known to daytime fans as the feisty Brenda Barrett on "General Hospital."
Asbury Park Press
Entertainment
Frontline Zolbetuximab/mFOLFOX6 Prolongs Survival in CLDN18.2+ Advanced Gastric/GEJ Adenocarcinoma
Frontline zolbetuximab plus mFOLFOX6 significantly improved progression-free and overall survival vs placebo/mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction adenocarc
OncLive
Oncology
Patients With Bone Sarcomas of Lower-Extremity and Non-Private Insurance Linked With Higher Amputation Rates, Worse Outcomes
Amputation is an independent predictor of poor outcomes among patients with high-grade bone sarcoma of lower extremity, and non-private insurance was found to be linked with increased likelihood of amputation and an advanced stage at presentation in this
OncLive
Oncology
ASCO GU 2022: Reflecting on RCC Data With Drs. Toni Choueiri and Peter Van Veldhuizen
This is a modal window. Technical details : Too many catalog media parameters were provided in this player. Please use only one of the following: videoId, playlistId, catalogSequence, or catalogSearch. Today- We are reporting from the 2022 Genitourinary C
OncLive
Oncology
FDA Approves Glofitamab-gxbm for Relapsed/Refractory DLBCL
The FDA has granted accelerated approval to glofitamab-gxbm (Columvi) for the treatment of adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified or large B-cell lymphoma arising from follicular lymphoma, aft
OncLive
Oncology

About

Gina Mauro

Feature writing

Adobe InDesign & Photoshop

Copyediting

Leadership

Social media

NewsGate CCI

iMovie

Newspaper design

Social networking

Creative writing

Adobe InCopy

Gina Mauro is Vice President, Content at MJH Life Sciences, overseeing OncLive®, Oncology Nursing News®, and Medical World News®. OncLive® also publishes the twice-monthly publication OncologyLive® and the quarterly publication Oncology Fellows, along with several print supplements and newsletters. OncLive® aims to provide oncology professionals with the resources and information they need to provide the best patient care.

Gina also serves as the lead anchor for OncLive News Network: On Location, which provides expert insights on practice-changing data from top oncology conferences. She is also the host of Medical World News® Behind the Science, program devoted to capturing the varying perspectives from experts around the world on the most pressing topics in health care.

Previously, she was a features writer for Asbury Park Press, where she educated readers on outdoor activities, community events, and home design projects, as well as spa, wellness, and fashion trends.

She also covered a variety of municipality topics, state-wide education issues, and breaking news. While at Asbury Park Press, she was a member of Gannett’s Talent Development Program, where she gained corporate experience and insights from the company's talented and motivated leaders.

As Editor-in-Chief of The Outlook, Monmouth University's student-run newspaper, she managed a staff of 50 writers, editors, photographers, designers and advertising managers combined. During her term, The Outlook was nationally awarded First Place with Special Merit by the American Scholastic Press Association twice.

Specialties: Strategic planning; leadership skills; news, feature, and medical writing and editing; Adobe Creative Suite; iMovie; GarageBand; social media; and more.